These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8537139)

  • 21. [New methods of administration of cephalosporins and aminoglycosides: relations between pharmacokinetics and pharmacodynamics].
    Kamnev IuV
    Antibiot Khimioter; 1992 Feb; 37(2):44-50. PubMed ID: 1514855
    [No Abstract]   [Full Text] [Related]  

  • 22. Oral and parenteral cephalosporins: the place of cephalexin in antibacterial therapy.
    Finland M
    Drugs; 1972; 3(1):1-8. PubMed ID: 5053818
    [No Abstract]   [Full Text] [Related]  

  • 23. Update on drug therapy. IV. Parenteral cephalosporins.
    Dahl SL; Elenbaas J; Hamburger S
    J Am Med Womens Assoc (1972); 1980 Apr; 35(4):99-100, 107-8. PubMed ID: 6246160
    [No Abstract]   [Full Text] [Related]  

  • 24. [Bacteriological, pharmacokinetic and clinical studies of 5% and 10% granules of cefdinir in the pediatric field].
    Toyonaga Y; Hatakeyama K; Yamori K; Sakaguchi N; Nakano K; Yamazaki M; Sugita M; Hori M
    Jpn J Antibiot; 1992 Jan; 45(1):48-73. PubMed ID: 1495196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo activity of DQ-2556, a new cephalosporin.
    Ishida Y; Miyazaki S; Yamaguchi K; Goto S
    Chemotherapy; 1995; 41(1):5-13. PubMed ID: 7875022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Barradell LB; Bryson HM
    Drugs; 1994 Mar; 47(3):471-505. PubMed ID: 7514976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibacterial activity of cefotaxime and other newer cephalosporins (in vitro and in vivo).
    Schrinner E; Limbert M; Penasse L; Lutz A
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():25-30. PubMed ID: 6252166
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacodynamics and pharmacokinetics of cefdinir, an oral extended spectrum cephalosporin.
    Guay DR
    Pediatr Infect Dis J; 2000 Dec; 19(12 Suppl):S141-6. PubMed ID: 11144395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ceftibuten: minimal inhibitory concentrations, postantibiotic effect and beta-lactamase stability--a rationale for dosing programs.
    Neu HC
    Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S88-92. PubMed ID: 7567316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parenteral cephalosporin therapy in ambulatory care: advantages and disadvantages.
    Esposito S
    Drugs; 2000; 59 Suppl 3():19-28; discussion 47-9. PubMed ID: 10845410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical evaluation of cefdinir 10% granules in children].
    Meguro H; Mori A; Fujii R; Terashima I
    Jpn J Antibiot; 1991 Oct; 44(10):1061-8. PubMed ID: 1762162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [new antimicrobial agent, cefpirome].
    Kobayashi H
    Jpn J Antibiot; 1994 May; 47(5):441-60. PubMed ID: 8051790
    [No Abstract]   [Full Text] [Related]  

  • 33. [Continuous treatment after parenteral cephalosporins. Peroral treatment is not available but temporary alternatives exist].
    Paulsen O; Forsgren A
    Lakartidningen; 1991 Sep; 88(39):3171-2. PubMed ID: 1656152
    [No Abstract]   [Full Text] [Related]  

  • 34. Cefixime in urinary tract infections with special reference to pediatrics: overview.
    Fanos V; Cataldi L
    J Chemother; 2001 Apr; 13(2):112-7. PubMed ID: 11330356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Possibilities for the use of basic cephalosporins].
    Rodloff AC; Knothe H
    Infection; 1993; 21 Suppl 1():S10-3. PubMed ID: 8314286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral versus initial intravenous therapy for urinary tract infections in young febrile children.
    Hoberman A; Wald ER; Hickey RW; Baskin M; Charron M; Majd M; Kearney DH; Reynolds EA; Ruley J; Janosky JE
    Pediatrics; 1999 Jul; 104(1 Pt 1):79-86. PubMed ID: 10390264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Oral cephalosporins].
    Kees F
    Med Monatsschr Pharm; 1992 Jan; 15(1):2-10. PubMed ID: 1542277
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis and biological activity of novel 3-(2-propenyl)-cephalosporins. I.
    Kim WJ; Ko KY; Kim H; Oh J
    J Antibiot (Tokyo); 1991 Oct; 44(10):1073-82. PubMed ID: 1955389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum bactericidal activity of newer oral cephalosporins in healthy volunteers.
    Dan M; Poch F; Edelman A; Asherov J; Hafely H; Atzmon Y
    J Antimicrob Chemother; 1998 Apr; 41(4):485-8. PubMed ID: 9598780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Oral cephalosporins of the 3rd generation].
    Kraeft H
    Internist (Berl); 1996 Mar; 37(3):319-23. PubMed ID: 8919952
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.